loading
前日終値:
$9.34
開ける:
$9.44
24時間の取引高:
110.85K
Relative Volume:
1.73
時価総額:
$118.80M
収益:
-
当期純損益:
$-8.89M
株価収益率:
-13.76
EPS:
-0.7
ネットキャッシュフロー:
$-6.48M
1週間 パフォーマンス:
+7.60%
1か月 パフォーマンス:
-13.32%
6か月 パフォーマンス:
-30.22%
1年 パフォーマンス:
-24.11%
1日の値動き範囲:
Value
$9.09
$9.90
1週間の範囲:
Value
$8.55
$9.90
52週間の値動き範囲:
Value
$8.06
$18.75

Greenwich Lifesciences Inc Stock (GLSI) Company Profile

Name
名前
Greenwich Lifesciences Inc
Name
セクター
Healthcare (1153)
Name
電話
203-434-3290
Name
住所
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
Name
職員
8
Name
Twitter
Name
次回の収益日
2024-11-08
Name
最新のSEC提出書
Name
GLSI's Discussions on Twitter

GLSI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
GLSI
Greenwich Lifesciences Inc
9.63 118.80M 0 -8.89M -6.48M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
490.47 128.67B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.49 60.99B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
599.87 36.96B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
236.75 29.89B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
252.77 25.74B 3.81B -644.79M -669.77M -6.24

Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-09-01 開始されました H.C. Wainwright Buy

Greenwich Lifesciences Inc (GLSI) 最新ニュース

pulisher
Apr 22, 2025

Greenwich LifeSciences (NASDAQ:GLSI) Price Target Raised to $39.00 at HC Wainwright - Defense World

Apr 22, 2025
pulisher
Apr 21, 2025

H.C. Wainwright Boosts Greenwich LifeSciences (GLSI) Price Target Amid Promising Trial Results | GLSI Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 16, 2025

(GLSI) Proactive Strategies - news.stocktradersdaily.com

Apr 16, 2025
pulisher
Apr 15, 2025

Greenwich Lifesciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 15, 2025
pulisher
Apr 15, 2025

Greenwich LifeSciences, Inc. SEC 10-K Report - TradingView

Apr 15, 2025
pulisher
Apr 14, 2025

Greenwich LifeSciences (GLSI) Expected to Announce Earnings on Monday - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

GREENWICH LIFESCIENCES Earnings Preview: Recent $GLSI Insider Trading, Hedge Fund Activity, and More - Nasdaq

Apr 12, 2025
pulisher
Apr 11, 2025

Greenwich Lifesciences Inc expected to post a loss of 21 cents a shareEarnings Preview - TradingView

Apr 11, 2025
pulisher
Apr 08, 2025

Greenwich Lifesciences CEO Snehal Patel acquires $32,760 in stock - Investing.com

Apr 08, 2025
pulisher
Apr 07, 2025

Greenwich LifeSciences CEO Snehal Patel buys $48,015 in common stock By Investing.com - Investing.com Canada

Apr 07, 2025
pulisher
Apr 07, 2025

Greenwich LifeSciences CEO Snehal Patel buys $48,015 in common stock - Investing.com Australia

Apr 07, 2025
pulisher
Apr 03, 2025

Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial - Curetoday

Apr 03, 2025
pulisher
Apr 03, 2025

Greenwich LifeSciences reports progress on FLAMINGO-01 trial By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

GLSI stock touches 52-week low at $9.05 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

GLSI stock touches 52-week low at $9.05 amid market challenges - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Greenwich Lifesciences Provides Global Update On Flamingo-01 - marketscreener.com

Apr 03, 2025
pulisher
Apr 03, 2025

Greenwich LifeSciences Provides Global Update on FLAMINGO-01 - GlobeNewswire

Apr 03, 2025
pulisher
Apr 03, 2025

Greenwich LifeSciences reports progress on FLAMINGO-01 trial - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Major Breakthrough: Cancer Prevention Trial Reports Positive Data, Elite Hospitals Join - Stock Titan

Apr 03, 2025
pulisher
Apr 02, 2025

Greenwich LifeSciences (GLSI) Shares Surge on Positive Phase 3 D - GuruFocus

Apr 02, 2025
pulisher
Apr 02, 2025

Flamingo cancer vaccine in phase III pink, Greenwich time nigh? - BioWorld MedTech

Apr 02, 2025
pulisher
Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

Greenwich LifeSciences stock rises on cancer shot data (GLSI) - Seeking Alpha

Apr 02, 2025
pulisher
Apr 02, 2025

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Greenwich Lifesciences Announces Positive Immune Response Data From FLAMINGO-01 Phase III Clinical Trial - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Clinical Trial Success: GLSI's Breast Cancer Therapy Shows Promising Results in Expanded Patient Group - Stock Titan

Apr 02, 2025
pulisher
Apr 02, 2025

Greenwich LifeSciences (NASDAQ:GLSI) Trading Down 6.7%Time to Sell? - MarketBeat

Apr 02, 2025
pulisher
Apr 01, 2025

Recent 15% decline may not have gone down well with Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders who've been purchasing recently - simplywall.st

Apr 01, 2025
pulisher
Mar 31, 2025

Greenwich LifeSciences Delays Yearly Report Filing - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

How To Trade (GLSI) - news.stocktradersdaily.com

Mar 31, 2025
pulisher
Mar 27, 2025

Greenwich LifeSciences Extends Lock-Up Period for Directors, Officers to March 2026 - MarketScreener

Mar 27, 2025
pulisher
Mar 27, 2025

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026 - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Major Insider Confidence Signal: Greenwich LifeSciences Leadership Locks Shares Until 2026 - Stock Titan

Mar 27, 2025
pulisher
Mar 26, 2025

HER2-Positive Breast Cancer Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, Ambrx, Alteogen - Barchart

Mar 26, 2025
pulisher
Mar 26, 2025

HER2-Positive Breast Cancer Pipeline 2025: Therapies, MOA - openPR.com

Mar 26, 2025
pulisher
Mar 25, 2025

GLSI stock touches 52-week low at $10.52 amid market challenges - Investing.com

Mar 25, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences gets DSMB approval to continue late-stage trial of GLSI-100 - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences Says Preliminary Safety Data for Breast Cancer Therapy Appears Consistent With Prior Trials - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences reports positive safety data on GLSI-100 - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences reports positive safety data on GLSI-100 By Investing.com - Investing.com UK

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01 - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich's Breast Cancer Drug Proves Safe in Phase III Trial, Building on 80% Recurrence Reduction - StockTitan

Mar 17, 2025
pulisher
Mar 10, 2025

Trading (GLSI) With Integrated Risk Controls - news.stocktradersdaily.com

Mar 10, 2025
pulisher
Mar 05, 2025

Non-Small Cell Lung Cancer Clinical Trial Pipeline | 100+ Companies Pioneering the Future of Treatment - openPR

Mar 05, 2025
pulisher
Mar 05, 2025

55% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is owned by insiders, and they've been buying recently - Yahoo Finance

Mar 05, 2025
pulisher
Feb 27, 2025

Learn to Evaluate (GLSI) using the Charts - news.stocktradersdaily.com

Feb 27, 2025
pulisher
Feb 22, 2025

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Sees Large Increase in Short Interest - MarketBeat

Feb 22, 2025
pulisher
Feb 21, 2025

Short Interest in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Increases By 5.1% - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Verra Mobility Corporation (NASDAQ: VRRM) - PR Newswire

Feb 20, 2025
pulisher
Feb 18, 2025

Pre-market Movers: TNXP, INBS, SMMT, NDRA... - RTTNews

Feb 18, 2025
pulisher
Feb 18, 2025

Research Analysts Set Expectations for GLSI FY2024 Earnings - MarketBeat

Feb 18, 2025

Greenwich Lifesciences Inc (GLSI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.27
price up icon 1.00%
$71.24
price up icon 2.49%
$32.19
price up icon 0.00%
$27.35
price up icon 8.45%
$104.68
price up icon 2.82%
biotechnology ONC
$252.77
price up icon 10.27%
大文字化:     |  ボリューム (24 時間):